| AAS | Acute aortic syndrome |
| ACS | Acute coronary syndrome |
| AIH | Aortic intramural hematoma |
| AV | Atrioventricular |
| CAD | Coronary artery disease |
| CT | Computed tomography |
| CIED | Cardiac implantable electronic devices |
| CMR | Cardiac Magnetic Resonance |
| CTRCT | Cancer-therapy-related cardiovascular toxicity |
| CRT | Cardiac resynchronization therapy |
| DCM | Dilated cardiomyopathy |
| ECV | Extracellular volume |
| EGE | Early gadolinium enhancement |
| EMB | Endomyocardial biopsy |
| FDG-PET | Fluorodeoxyglucose Positron Emission Tomography |
| GBCA | Gadolinium-based contrast agents |
| HCM | Hypertrophic cardiomyopathy |
| HF | Heart failure |
| ICD | Implantable cardioverter defibrillator |
| ICU | Intensive care unit |
| IMH | Intramyocardial hemorrhage |
| MACE | Major adverse cardiovascular event |
| MI | Myocardial infarction |
| MRI | Magnetic resonance imaging |
| LGE | Late gadolinium enhancement |
| LV | Left ventricle |
| LVEF | Left ventricular ejection fraction |
| MINOCA | Myocardial infarction with nonobstructive coronary arteries |
| MVO | Microvascular obstruction |
| STEMI | ST-elevation myocardial infarction |
| SCD | Sudden cardiac death |
| TTS | Takotsubo syndrome |